Migraine isn’t just a bad headache. It’s a complex neurological disorder that affects over 1 billion people worldwide — making it the third most prevalent and second most disabling condition globally. For those who experience migraine, the distinction between “headache” and “migraine” is immediately clear: one is an annoyance that responds to over-the-counter medication; the other is a debilitating neurological event that can last days, force retreat to a dark room, and fundamentally disrupt life.

The numbers tell a sobering story. Migraine affects approximately 12% of the population, but the burden is far from equal — women are three times more likely to experience migraines than men, and migraine prevalence peaks during the most productive years of life (ages 25-55). The World Health Organization ranks migraine as one of the top causes of disability worldwide, ahead of diabetes, epilepsy, and Alzheimer’s disease combined.

Beyond statistics, migraine represents lost days — lost work days (migraine causes more missed work than any other neurological condition), lost social occasions, lost quality time with family. The economic burden exceeds $78 billion annually in the United States alone, accounting for both direct medical costs and lost productivity. But the personal cost is incalculable: relationships strained by canceled plans, careers limited by unpredictable attacks, constant fear of the next episode.

What makes migraine particularly frustrating is its invisibility. Unlike a broken bone or visible illness, migraine often goes unrecognized by others — including some healthcare providers. “It’s just a headache” trivializes an experience that can involve crushing head pain, nausea so severe it prevents eating or drinking, sensitivity to light and sound that makes normal environments unbearable, and neurological symptoms that can mimic stroke. Many people with migraine suffer for years before receiving accurate diagnosis and effective treatment.

Yet here’s what gives hope: migraine, while currently incurable, is highly manageable. Understanding migraine triggers — which for many people include hormonal fluctuations, nutritional deficiencies, inflammatory processes, and metabolic imbalances that can be detected through blood testing — enables targeted prevention. Lifestyle modifications, appropriate medications, and addressing underlying metabolic issues can dramatically reduce attack frequency and severity.

This is where blood testing transforms migraine management. While migraine is primarily diagnosed clinically (based on symptoms and pattern), blood tests can reveal critical contributing factors: hormonal imbalances (estrogen fluctuations, thyroid dysfunction), nutritional deficiencies (magnesium, riboflavin, CoQ10, vitamin D), inflammatory markers, and metabolic conditions that lower migraine threshold or trigger attacks. Identifying and correcting these factors often provides relief when standard treatments alone have failed.

Migraine isn’t a character flaw or a sign of weakness. It’s a genetic neurological condition with identifiable physiological mechanisms — and those mechanisms can often be addressed.

Quick Summary:

• Migraine affects over 1 billion people worldwide — third most prevalent condition globally, second most disabling
• Not just a headache: Complex neurological disorder with distinct phases, symptoms, and mechanisms
• Gender disparity: Women are 3x more likely than men to experience migraine, largely due to hormonal influences
• Characteristic symptoms: Moderate to severe throbbing pain (often one-sided), nausea/vomiting, photophobia, phonophobia, lasting 4-72 hours
• Aura in 25%: Neurological symptoms (visual disturbances, sensory changes, language difficulty) that precede headache
• Distinct from tension headache: More severe, disabling, with associated symptoms tension headaches lack
• Multiple trigger categories: Hormonal (menstruation, menopause), dietary (certain foods, skipped meals, dehydration), environmental (light, sound, weather), sleep-related, stress
• Blood tests reveal contributors: Hormone panels, vitamin D, magnesium, thyroid function, inflammatory markers (hs-CRP), metabolic markers
• Hormonal migraine common: Menstrual migraine affects 60% of women with migraine; estrogen fluctuation is a powerful trigger
• Nutritional deficiencies matter: Magnesium, riboflavin (B2), CoQ10, and vitamin D deficiencies all increase migraine frequency
• Chronic migraine defined: 15+ headache days per month, with at least 8 being migraine days — affects 2% of population
• Prevention is possible: Lifestyle modifications, prophylactic medications, trigger avoidance, and addressing underlying metabolic issues reduce frequency
• Treatment has evolved: CGRP inhibitors, gepants, and triptans join older preventives and acute treatments
• Quality of life impact: Migraine causes more disability-adjusted life years than epilepsy, multiple sclerosis, and Parkinson’s disease combined

---

What Is Migraine?

Migraine is a primary headache disorder — meaning the headache itself is the condition, not a symptom of something else like infection, tumor, or injury. It’s characterized by recurrent attacks of moderate to severe head pain with specific associated features that distinguish it from other headache types.

The Migraine Attack: Four Phases

Migraine unfolds in distinct phases, though not everyone experiences all four:

1. Prodrome (premonitory phase): 
Hours to days before headache begins, subtle changes signal an approaching attack. These might include neck stiffness, food cravings (especially sweets), frequent yawning, mood changes (irritability or euphoria), increased urination, or fluid retention. Recognizing prodrome symptoms can allow early intervention. 

2. Aura (in ~25% of migraineurs): 
Reversible neurological symptoms that typically develop over 5-20 minutes and last less than 60 minutes. Visual aura is most common — zigzag lines, blind spots, shimmering lights, tunnel vision. Sensory aura (tingling or numbness spreading from fingers up the arm) and language aura (difficulty finding words, slurred speech) occur less commonly. Aura symptoms can be frightening and are sometimes mistaken for stroke. 

3. Headache phase: 
The attack itself. Moderate to severe throbbing or pulsating pain, often unilateral (one-sided) though can be bilateral. Pain typically worsens with physical activity. This phase is accompanied by nausea (in 80%), vomiting (in 30-50%), photophobia (light sensitivity), and phonophobia (sound sensitivity). Duration: 4-72 hours if untreated. 

4. Postdrome (“migraine hangover”): 
After the headache resolves, many people experience lingering effects — fatigue, difficulty concentrating, mood changes, muscle weakness or soreness. This phase can last 24-48 hours, during which the person doesn’t feel “right” even though the headache has ended.

Understanding these phases helps with diagnosis, treatment timing, and patient education. Early treatment during prodrome or aura is often more effective than waiting until pain is severe.

Migraine vs. Tension Headache vs. Other Headaches

Distinguishing migraine from other headache types is critical for appropriate treatment:

Feature	Migraine	Tension Headache
Pain quality	Pulsating, throbbing	Pressing, tightening (band-like)
Intensity	Moderate to severe	Mild to moderate
Location	Often unilateral	Typically bilateral
Duration	4-72 hours	30 minutes to 7 days
Nausea/vomiting	Common	Absent
Light/sound sensitivity	Both typical	One or neither
Worsened by activity	Yes	No
Aura	Possible (25%)	Never

Cluster headache is another distinct entity — excruciating pain around one eye, with tearing and nasal congestion on that side, attacks lasting 15-180 minutes, occurring in clusters (multiple attacks daily for weeks to months). Rare but unmistakable.

Medication overuse headache develops from frequent use of acute headache medications (10+ days per month). Common in people with migraine who overuse triptans, combination analgesics, or opioids.

Types of Migraine

Migraine without aura (75%): The most common type. Recurrent attacks with typical migraine characteristics but no aura phase.

Migraine with aura (25%): Includes the aura phase before or during headache. Aura can occasionally occur without subsequent headache (particularly in older adults), called “migraine equivalent” or “acephalgic migraine.”

Chronic migraine: Defined as 15 or more headache days per month, with at least 8 days meeting migraine criteria, for more than 3 months. Affects about 2% of the population. Often evolves from episodic migraine through transformation driven by medication overuse, obesity, depression, or other factors.

Menstrual migraine: Attacks occurring predictably in relation to menstruation (typically 2 days before through 3 days after onset). Pure menstrual migraine occurs only during this window; menstrually-related migraine occurs at other times too but consistently worsens with menstruation.

Hemiplegic migraine: Rare subtype with aura including motor weakness (temporary paralysis on one side). Can be familial or sporadic. Requires careful evaluation to rule out stroke.

Vestibular migraine: Characterized by vertigo or dizziness as a prominent feature, with or without headache. Underdiagnosed cause of recurrent dizziness.

---

Causes and Mechanisms

The Migraine Brain: Neurological Basis

Migraine is fundamentally a disorder of the brain — specifically, a disorder of neuronal excitability and neurovascular regulation. While the exact mechanisms remain incompletely understood, key processes include:

Cortical spreading depression (CSD): A wave of neuronal and glial depolarization that spreads across the cortex, followed by suppression of electrical activity. CSD is thought to generate aura symptoms and may trigger the cascade leading to headache pain. This phenomenon can be triggered by various stimuli in susceptible brains.

Trigeminovascular activation: The trigeminal nerve innervates blood vessels in the meninges (coverings of the brain). Activation of these pain fibers releases inflammatory neuropeptides (CGRP, substance P, neurokinin A) that cause vasodilation and neurogenic inflammation. This is the source of migraine pain.

CGRP (calcitonin gene-related peptide): A key mediator of migraine pain. CGRP levels rise during migraine attacks. Blocking CGRP (with monoclonal antibodies or small molecule antagonists) prevents or treats migraine, confirming its central role.

Brainstem and hypothalamic involvement: The brainstem and hypothalamus regulate pain processing, sleep-wake cycles, stress responses, and autonomic function — all relevant to migraine. Functional imaging shows abnormal activation in these areas during attacks. This explains prodrome symptoms (yawning, food cravings, mood changes) that precede headache.

Central sensitization: Repeated migraine attacks can sensitize central pain pathways, lowering the threshold for future attacks. This may explain transformation from episodic to chronic migraine.

Genetic Factors

Migraine runs strongly in families. Having one parent with migraine increases a child’s risk to 40%; if both parents have migraine, the risk rises to 75-90%. Twin studies suggest 40-60% of migraine susceptibility is genetic.

Migraine is polygenic — influenced by many genes, each contributing small effects. Over 40 genetic loci have been associated with migraine risk, involving genes related to vascular function, neuronal channels, neurotransmitter regulation, and pain processing.

Familial hemiplegic migraine is an exception — a rare form caused by mutations in single genes (CACNA1A, ATP1A2, SCN1A) that follow Mendelian inheritance. Studying these rare genetic forms has illuminated mechanisms relevant to common migraine.

Hormonal Influences

The 3:1 female-to-male migraine ratio points to profound hormonal influence, particularly estrogen:

Estrogen withdrawal triggers migraine: Many women experience migraine during the late luteal phase or menstruation, when estrogen levels drop precipitously. Pure menstrual migraine occurs exclusively during this window.

Pregnancy effects vary: Many women (60-70%) experience migraine improvement during pregnancy, particularly the second and third trimesters when estrogen levels are high and stable. Others, especially those with menstrual migraine, continue attacks or worsen.

Menopause transition: Perimenopause is often the worst time for migraine due to erratic estrogen fluctuations. After menopause, when estrogen stabilizes at a lower level, many women experience improvement.

Hormonal contraceptives: Combined hormonal contraceptives (containing estrogen) can worsen migraine in some women, improve it in others, or have no effect. The effect depends on formulation, dosing, and individual susceptibility. Estrogen-containing contraceptives should generally be avoided in women with migraine with aura due to increased stroke risk.

Hormone replacement therapy (HRT): Can help or worsen migraine in postmenopausal women. Transdermal estrogen (avoiding first-pass metabolism and providing more stable levels) may be better tolerated than oral formulations.

Testing estrogen, progesterone, FSH, and LH can help identify hormonal patterns contributing to migraine and guide hormonal interventions when appropriate.

---

Migraine Triggers: Identification and Management

Triggers are factors that, in susceptible individuals, can precipitate a migraine attack. Importantly, triggers aren’t causes — they don’t create migraine, they unmask the underlying neurological susceptibility. Understanding personal triggers enables avoidance or mitigation.

Hormonal Triggers

• Menstruation: Estrogen withdrawal before/during period
• Ovulation: Mid-cycle estrogen surge in some women
• Hormonal contraceptives: Particularly the hormone-free interval
• Pregnancy: Hormonal changes, particularly first trimester
• Perimenopause: Erratic estrogen fluctuations

Dietary Triggers

Food triggers are highly individual. Common culprits include:

• Alcohol: Especially red wine, but any alcohol in susceptible individuals
• Caffeine: Both consumption (in sensitive people) and withdrawal (in regular users)
• Aged cheeses: Contain tyramine, a vasoactive compound
• Processed meats: Nitrates/nitrites in cured meats
• MSG (monosodium glutamate): Common in Asian cuisine and processed foods
• Aspartame: Artificial sweetener
• Chocolate: Contains multiple potential triggers
• Skipped meals: Fasting or irregular eating patterns
• Dehydration: Not consuming enough water

Food trigger identification is best done through systematic elimination and reintroduction rather than avoiding long lists of “possible” triggers indefinitely. A headache diary helps identify true personal triggers.

Environmental Triggers

• Bright or flickering lights: Sunlight, fluorescent lights, computer screens
• Strong odors: Perfumes, cleaning products, smoke
• Loud or sustained noise
• Weather changes: Barometric pressure shifts, humidity, temperature extremes
• High altitude

Sleep and Lifestyle Triggers

• Too little sleep: Sleep deprivation lowers migraine threshold
• Too much sleep: Oversleeping (weekend lie-ins) can trigger attacks
• Irregular sleep schedule: Shift work, jet lag
• Stress: Both acute stress and stress letdown (post-stress migraine)
• Physical exertion: Intense exercise in some individuals

Creating a Trigger Plan

Keeping a detailed headache diary for 2-3 months is the gold standard for identifying personal triggers. Record:

• Date and time of attack onset
• Pain characteristics (location, intensity, quality)
• Associated symptoms
• Menstrual cycle day (for women)
• Foods eaten in 24 hours before attack
• Sleep quantity and quality
• Stress levels
• Weather conditions
• Medications taken and their effectiveness

Patterns emerge over time. Some triggers are absolute and reproducible; others are threshold-lowering factors that increase susceptibility without guaranteeing an attack.

---

Blood Testing for Migraine

While migraine is diagnosed clinically (based on symptoms, not blood tests), targeted blood testing can reveal metabolic, hormonal, and nutritional factors that contribute to migraine frequency and severity. Addressing these factors often reduces attack frequency even when standard migraine treatments have plateaued.

Why Blood Tests Matter in Migraine

Blood tests serve several purposes:

• Identify nutritional deficiencies that lower migraine threshold
• Detect hormonal imbalances driving menstrual or perimenopausal migraine
• Reveal inflammatory processes that increase neuronal excitability
• Rule out secondary causes of headache (thyroid disorders, anemia)
• Guide targeted supplementation and hormonal interventions
• Monitor treatment effects when correcting deficiencies

Recommended Blood Tests

Magnesium: Magnesium deficiency is common in migraineurs. Magnesium stabilizes neuronal membranes, blocks NMDA receptors, and prevents cortical spreading depression. Supplementation reduces migraine frequency in deficient individuals. Serum magnesium may not reflect intracellular stores; RBC magnesium is more accurate but less available.

Vitamin D: Low vitamin D is associated with increased migraine frequency and severity. Vitamin D has neuroprotective and anti-inflammatory effects. Correcting deficiency may reduce attack frequency. Target levels for migraine prevention may be higher than standard sufficiency thresholds.

Vitamin B12 and Folate: B vitamins, particularly riboflavin (B2), have preventive effects in migraine. While serum B12 and folate testing is standard, riboflavin isn’t typically measured but can be supplemented empirically based on healthcare provider recommendations.

Thyroid Function (TSH, Free T4, Free T3): Both hyperthyroidism and hypothyroidism can trigger or worsen headaches. Treating thyroid dysfunction often improves headache patterns. Subclinical thyroid disease may also contribute.

hs-CRP (High-Sensitivity C-Reactive Protein): Marker of systemic inflammation. Chronic inflammation may increase migraine susceptibility. Elevated hs-CRP suggests investigating and addressing inflammatory sources.

Estradiol, Progesterone, FSH, LH: For women with menstrual migraine or perimenopausal symptoms, hormone testing identifies patterns contributing to attacks. Testing should be timed to menstrual cycle (day 3 for baseline FSH/LH/estradiol; day 21 for progesterone in regular cycles).

Hemoglobin and Ferritin: Anemia can worsen headaches. Iron deficiency, even without anemia, may lower migraine threshold. Ferritin reflects iron stores; deficiency is common in menstruating women.

Fasting Glucose and HbA1c: Hypoglycemia (low blood sugar from skipped meals or insulin surges) is a common trigger. Insulin resistance and prediabetes may also be relevant. Maintaining stable blood sugar reduces attacks in susceptible individuals.

CoQ10: Not typically measured via blood test (specialized testing required), but empirical supplementation has shown preventive effects in some studies. CoQ10 supports mitochondrial function, which may be impaired in migraine.

When to Test

Consider comprehensive blood work if:

• Migraine frequency is increasing despite standard treatment
• Menstrual pattern to attacks suggests hormonal involvement
• Symptoms suggest possible thyroid dysfunction (fatigue, weight changes, temperature sensitivity)
• Dietary quality is poor or restricted (vegetarian/vegan, limited variety)
• Perimenopausal or postmenopausal with new or worsening headaches
• Chronic fatigue accompanies migraine
• Standard preventive treatments have failed or been poorly tolerated

---

Prevention and Treatment

Lifestyle and Behavioral Approaches

Maintain regular schedule: Consistent sleep (same bedtime/wake time daily), regular meals, steady physical activity. Regularity reduces trigger exposure.

Manage stress: Stress management techniques (cognitive behavioral therapy, mindfulness, biofeedback, relaxation training) reduce attack frequency. Particularly helpful for stress-triggered migraine.

Exercise regularly: Moderate aerobic exercise 30-40 minutes, 3-5 days weekly reduces migraine frequency. Avoid intense exertion if it triggers attacks; build up gradually.

Hydration: Maintain adequate fluid intake. Dehydration is a common, preventable trigger.

Dietary modifications: Identify and avoid personal food triggers. Some find benefit from specific diets (low tyramine, elimination diets), but evidence is limited. Avoid drastic diets or prolonged fasting.

Limit caffeine: Moderate, consistent caffeine intake is fine for most. Avoid excessive use and sudden withdrawal.

Sleep hygiene: Maintain good sleep habits. Treat underlying sleep disorders (sleep apnea, insomnia) if present.

Nutritional Supplements with Evidence

Magnesium: Magnesium supplementation has shown benefit in reducing migraine frequency. Most effective forms include magnesium oxide and magnesium dicitrate. Benefits typically become apparent after consistent use over several months. Well-tolerated; main side effect is bright yellow urine from the supplement.

Riboflavin (Vitamin B2): High-dose riboflavin supplementation has demonstrated benefit in migraine prevention. Benefits typically take several months to become apparent. Well-tolerated; main side effect is bright yellow urine.

Coenzyme Q10: CoQ10 supplementation supports mitochondrial function and may reduce migraine frequency in some individuals.

Vitamin D: If deficient, correct with supplementation (dosing based on baseline level).

Omega-3 fatty acids: EPA and DHA supplementation may reduce inflammation and help decrease migraine attack frequency.

Feverfew and butterbur: Herbal supplements with some evidence, though quality and standardization vary. Butterbur requires PA-free preparation to avoid liver toxicity.

Acute Treatment

Over-the-counter: NSAIDs (ibuprofen, naproxen), acetaminophen, aspirin. Combination products (aspirin/acetaminophen/caffeine) effective for mild-moderate attacks. Risk: medication overuse headache if used too frequently.

Triptans: Serotonin receptor agonists (sumatriptan, rizatriptan, zolmitriptan, others). First-line prescription treatment for moderate-severe migraine. Most effective when taken early. Available as tablets, nasal spray, injection. Contraindicated with cardiovascular disease, uncontrolled hypertension.

Gepants (CGRP antagonists): Newer class (ubrogepant, rimegepant) that block CGRP receptors. Effective for acute treatment, some also approved for prevention. Fewer cardiovascular contraindications than triptans.

Ditans: Serotonin 1F agonists (lasmiditan). Alternative for those who can’t take triptans. May cause dizziness; don’t drive for 8 hours after taking.

Anti-nausea medications: Metoclopramide, prochlorperazine. Treat nausea, may have independent anti-migraine effect.

Preventive Medications

Consider prevention if:

• Frequent migraine days per month significantly impacting quality of life
• Attacks significantly disable despite acute treatment
• Acute treatments contraindicated or poorly tolerated
• Frequent use of acute medications risking medication overuse headache
• Special circumstances (hemiplegic migraine, prolonged aura)

CGRP monoclonal antibodies: Monthly or quarterly injections (erenumab, fremanezumab, galcanezumab, eptinezumab). Specifically developed for migraine prevention. Reduce monthly migraine days in many patients. Well-tolerated, few side effects. First-line prevention option.

Beta-blockers: Propranolol, metoprolol. Can reduce attack frequency. Side effects: fatigue, low blood pressure, exercise intolerance. Contraindicated in asthma.

Antidepressants: Amitriptyline, venlafaxine. Effective even in non-depressed patients. Amitriptyline side effects: sedation, dry mouth, weight gain.

Anticonvulsants: Topiramate, valproate. Topiramate effective but side effects common (cognitive difficulties, paresthesias, weight loss). Valproate contraindicated in pregnancy.

Botulinum toxin (Botox): FDA-approved for chronic migraine (frequent headache days per month). Injections administered periodically. Reduces headache days in responders.

---

Migraine in Special Populations

Migraine and Pregnancy

Pregnancy creates both challenges and opportunities. Many women (60-70%) improve during pregnancy, particularly second and third trimesters. However, others worsen or develop new attacks.

First trimester: Often the most difficult. Avoid most migraine medications. Safe options: acetaminophen, limited use of metoclopramide for nausea.

Second/third trimester: More treatment options available if needed. Avoid triptans, ergots, NSAIDs (especially third trimester), most preventives.

Postpartum: Migraine often returns within weeks after delivery as estrogen levels drop. Breastfeeding may delay return in some women.

Preeclampsia warning: New-onset severe headache in pregnancy, especially with visual changes or hypertension, requires urgent evaluation to rule out preeclampsia or other dangerous causes.

Migraine in Children and Adolescents

Migraine often begins in childhood. Before puberty, boys and girls are equally affected; after puberty, female predominance emerges.

Differences in children: Attacks may be shorter, more often bilateral, prominent nausea/vomiting. Abdominal migraine (recurrent abdominal pain with nausea) is a childhood variant.

Treatment: Lifestyle regularity especially important. Ibuprofen or acetaminophen for acute treatment. Triptans approved for adolescents. Prevention if frequent or disabling.

Migraine in Older Adults

Migraine often improves with age, but some continue attacks into older adulthood. New-onset migraine after age 50 is uncommon and warrants thorough evaluation to rule out secondary causes.

Late-life migraine accompaniments: Some older adults experience aura without headache — visual disturbances, sensory symptoms, or speech difficulty without subsequent pain. Important to distinguish from TIA/stroke.

Treatment considerations: Cardiovascular disease more common; triptans may be contraindicated. Drug interactions with other medications more likely.

---

Living with Migraine

Practical Strategies

Keep a headache diary: Essential for identifying patterns, triggers, and treatment effectiveness. Apps make this easier (Migraine Buddy, N1-Headache, others).

Have an action plan: Know what to take, when to take it, and when to seek emergency care. Early treatment is more effective.

Create a migraine-friendly environment: At home and work, reduce known triggers. Adjust lighting, minimize noise, have dark/quiet retreat space available.

Communicate with employers/school: Migraine is a legitimate medical condition. Accommodations may include flexible scheduling, work-from-home options, or reduced sensory stimulation.

Build a support network: Connect with others who understand. Family education helps them recognize migraine isn’t “just a headache.”

Plan around attacks: For important events, discuss preventive strategies with your provider. Short-term prevention (bridge therapy) may be appropriate.

When to Seek Emergency Care

Most migraines, though severe, don’t require emergency treatment. However, seek immediate care for:

• “Thunderclap” headache: Sudden severe headache reaching maximum intensity within seconds to minutes
• First or worst headache of your life
• Headache with fever, stiff neck, confusion, seizure
• Headache after head trauma
• Headache with weakness, numbness, vision loss, difficulty speaking — especially if these don’t follow typical aura pattern
• Headache with progressively worsening pattern
• New headache after age 50

---

The Future of Migraine Treatment

Migraine research is advancing rapidly. The development of CGRP-targeting medications represents the first migraine-specific treatments developed from understanding disease mechanisms. This success has energized the field.

Emerging approaches include:

• New neuromodulation devices (external and implantable)
• Additional CGRP pathway targets
• Personalized medicine approaches based on genetic profiling
• Better understanding of migraine comorbidities and their treatment
• Novel preventive strategies targeting identified mechanisms

For the first time, migraine is receiving attention commensurate with its global disease burden. Research funding is increasing. New treatments are in development. Public awareness is growing. The future holds promise for better prevention and treatment.

Every article at Pin Health is held to the highest editorial standards for accuracy, sourcing, and medical integrity. All content is medically reviewed by a U.S.-licensed physician before publication. To learn how we deliver trusted health, lifestyle, and longevity insights, read about our editorial process.